Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel two-step route using bis-ketal glucose enables high-purity chiral monomers for reusable polymer-supported asymmetric catalysis applications.
Patent CN113548999A details a novel Pd-catalyzed route to 3-(2,3-butadienyl)oxindoles with high enantioselectivity, offering cost-effective solutions for antiviral drug development.
Patent CN105348044B details a green synthetic route for (S)-Virol A. Offers high ee value and scalable process for pharmaceutical and agrochemical research applications.
Patent CN111662331B discloses novel phosphine ligands enabling high-yield, high-ee asymmetric Suzuki coupling for complex biaryl pharmaceutical intermediates.
Patent CN103755554A details a novel cobalt-catalyzed Kumada coupling route for high-purity (S)-fenoprofen, offering significant cost reduction in NSAID manufacturing.
Patent CN1233608C details a novel route for (2S,3S,7S)-3,7-dimethyl-2-pentadecanol esters using (S)-malic acid, offering cost reduction in agrochemical manufacturing.
Patent CN111770917B details a novel asymmetric route for Factor XIa inhibitor intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced asymmetric coupling patent enables high-purity chiral alkyne production with significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN107304179B details a novel synthesis for LCZ696 intermediates featuring improved stereocontrol and yield. Ideal for reliable pharmaceutical intermediate suppliers seeking scalable routes.
Patent CN112930348A details an enzymatic route for Safraninib, improving yield and reducing waste compared to chiral resolution methods.
Patent CN115557873A details a novel asymmetric synthesis for Brivaracetam methyl ester impurity, offering high purity and cost-effective production for quality control standards.
Novel patent CN119552158A details efficient Orforglipron synthesis using tert-butyl ester protection, offering cost reduction and scalability for pharmaceutical manufacturing supply chains.
Novel chiral preparation of Cinacalcet HCl via Patent CN101993379B. Eliminates toxic reductants, ensures high optical purity, and offers scalable API intermediate manufacturing solutions.
Patent CN102030690B details a novel two-step synthesis of axially chiral bissulfoxide ligands, offering high enantioselectivity and streamlined manufacturing for asymmetric catalysis applications.
Discover advanced catalytic methods for pyrimidylcyclopentane intermediates. Enhance purity and reduce costs in AKT inhibitor manufacturing with our scalable solutions.
Patent CN113512733B details an electrochemical NHK reaction for Eribulin intermediate ERB, offering greener synthesis, reduced reaction time, and improved scalability for pharmaceutical manufacturing.
Novel patent CN103709092B offers simplified Mitiglinide Calcium synthesis. Enhances purity, reduces cost, ensures supply chain reliability for pharmaceutical manufacturers.
Novel oxaspiro diphosphine ligand synthesis enables >99% ee hydrogenation. Reliable supplier for high-purity chiral intermediates.
Patent CN111440205B reveals a novel diboronic acid diol ester enabling high-yield, 99% ee chiral 1,2-diamine synthesis with recyclable reagents for cost-effective manufacturing.
Novel patent CN107540574A offers safe, cost-effective R-biphenylalaninol synthesis for Sacubitril. Enhances supply chain reliability and reduces manufacturing costs significantly.